ライフサイエンスコーパス: T-cell leukemia

1 (prostate), MDA-MB-231 (breast), and Jurkat (T-cell leukemia).

2 ackfan anemia (DBA), congenital asplenia and T cell leukemia.

3 a spectrum of human malignancies, including T cell leukemia.

4 d retroviruses with the former causing adult T cell leukemia.

5 fficacy in mouse models of human sarcoma and T cell leukemia.

6 pathy/tropical spastic paraparesis and adult T cell leukemia.

7 ons in both the induction and maintenance of T cell leukemia.

8 perturbation of its activity often leads to T cell leukemia.

9 and MAPK kinase activities in CD3-activated T cell leukemia.

10 ll lines and dampens global transcription in T cell leukemia.

11 ed ribosomal mutation in acute lymphoblastic T-cell leukemia.

12 of thymocytes, and subsequent generation of T-cell leukemia.

13 ors was associated with improved outcomes in T-cell leukemia.

14 e 1 (HTLV-1) is the causative agent of adult T-cell leukemia.

15 humans and is etiologically linked to adult T-cell leukemia.

16 cell transformation and development of adult T-cell leukemia.

17 event in the process of ZNF198-FGFR1-induced T-cell leukemia.

18 irus type-1 is the causative agent for adult T-cell leukemia.

19 nt of the aggressive and fatal disease adult T-cell leukemia.

20 1 (HTLV-1) is the etiological agent of adult T-cell leukemia.

21 infects CD4+ T lymphocytes and causes adult T-cell leukemia.

22 investigate the role of this interaction in T-cell leukemia.

23 Nbn (-/mid8) mice developed highly penetrant T cell leukemias.

24 m cells downstream of MYC in human and mouse T-cell leukemias.

25 y reduced in CD19(+) spleen B cells from Emu-T cell leukemia 1 (TCL1) transgenic mice relative to the

26 tudies revealed that ROR1 could complex with T-cell leukemia 1 (TCL1) in CLL, we crossed these animal

27 T-cell leukemia 1 (TCL1), the AKT modulator and proto-on

28 Constitutive activation of the T-cell leukemia 1A (TCL1A) oncogene distinguishes the (p

29 T-cell leukemia 1A (TCL1A) was the gene closest (926-700

30 The T cell leukemia 3 (Tlx3) gene has been implicated in spe

31 photropic virus type 1 (HTLV-1) causes adult T-cell leukemia, a disease commonly associated with hype

32 minimal overlap with known Notch targets in T cell leukemia and developing T cells, highlighting the

33 tained diseases, such as autoimmunity, adult T cell leukemia and HIV-1.

34 ogenesis related to the progression of adult T cell leukemia and HTLV-1-associated myelopathy/tropica

35 ntrolled tumor growth in xenograft models of T cell leukemia and pancreatic cancer.

36 ic virus type 1 (HTLV-1) mainly causes adult T cell leukemia and predominantly immortalizes/transform

37 genetic aberrations that promote acute B and T cell leukemias and the mechanisms of cell transformati

38 r different cancer cell lines, in this case, T-cell leukemia and B-cell lymphoma.

39 A056 selectively targets acute lymphoblastic T-cell leukemia and cutaneous T-cell lymphoma.

40 e 1 (HTLV-1) is the causative agent of adult T-cell leukemia and HTLV-1-associated myelopathy/tropica

41 virus type 1 (HTLV-1) infection causes adult T-cell leukemia and is associated with a variety of lymp

42 mature lymphocytes, develop multiple B- and T-cell leukemia and lymphoma subtypes, supporting an onc

43 -1), an etiological factor that causes adult T-cell leukemia and lymphoma, has a crucial role in init

44 ntial therapeutic agent for the treatment of T-cell leukemia and lymphoma.

45 enic mutations in NOTCH1 are common in human T-cell leukemia and lymphomas.

46 There are 3 categories: chronic T-cell leukemia and NK-cell lymphocytosis, which are sim

47 virus type 1 (HTLV-1) infection causes adult T-cell leukemia and several lymphocyte-mediated inflamma

48 kemia virus type 1 (HTLV-1)-associated adult T-cell leukemia and T-cell lymphoma (ATL) are aggressive

49 Tipifarnib reduced cell viability in these T-cell leukemia and TCL cell lines, induced apoptosis an

50 ifarnib as a potential therapeutic option in T-cell leukemia and TCL.

51 with several serious diseases, such as adult T-cell leukemia and tropical spastic paraparesis/myelopa

52 ry tumor virus (MMTV) variant, often induces T-cell leukemias and lymphomas by c-myc activation follo

53 Patients diagnosed with T-cell leukemias and T-cell lymphomas (TCLs) still have

54 Patients who have T-cell leukemia appear to have a better outcome with all

55 and constitutive Notch signaling potentiates T cell leukemia as well as Drosophila neuroblast tumors.

56 BZ is important for the development of adult T-cell leukemia associated with HTLV-1 infection.

57 All R26-betacat mice develop T-cell leukemias at 5 to 6 months of age.

58 Adult T cell leukemia (ATL) is a serious form of cancer with a

59 pontaneous proliferation of smoldering adult T cell leukemia (ATL) T cells.

60 fatal hematopoietic malignancy termed adult T cell leukemia (ATL).

61 e 1 (HTLV-1) is the causative agent of adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/t

62 1 (HTLV-1) is the etiological agent of adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/t

63 Adult T-cell leukemia (ATL) and human T-cell lymphotropic viru

64 s-1 (HTLV-I) is the etiologic agent of adult T-cell leukemia (ATL) and the neurological disorder HTLV

65 oup that first identified a cluster of adult T-cell leukemia (ATL) cases in Japan, provided conclusiv

66 In most adult T-cell leukemia (ATL) cells, Tax oncoprotein expression

67 Adult T-cell leukemia (ATL) is a fatal malignancy caused by in

68 Adult T-cell leukemia (ATL) is an aggressive malignancy of CD4

69 Adult T-cell leukemia (ATL) is an aggressive T-cell malignancy

70 Adult T-cell leukemia (ATL) is caused by human T-cell lymphotr

71 The etiologic agent of adult T-cell leukemia (ATL) is human T cell lymphotropic virus

72 Adult T-cell leukemia (ATL), a heterogeneous disease, can be d

73 s are implicated in the development of adult T-cell leukemia (ATL), a T-cell malignancy caused by HTL

74 e-I (HTLV-I) is the etiologic agent of adult T-cell leukemia (ATL), an aggressive lymphoproliferative

75 rus type 1 (HTLV-I) is associated with adult T-cell leukemia (ATL), an aggressive lymphoproliferative

76 irus type 1 (HTLV-1) that recapitulate adult T-cell leukemia (ATL)-like leukemic symptoms and display

77 use a rare form of leukemia designated adult T-cell leukemia (ATL).

78 1 (HTLV-I) is the etiological agent of adult T-cell leukemia (ATL).

79 nic retrovirus etiologically causal of adult T-cell leukemia (ATL).

80 hat induces a fatal T-cell malignancy, adult T-cell leukemia (ATL).

81 sidered to be the etiological agent of adult T-cell leukemia (ATL).

82 orldwide and is the causative agent of adult T-cell leukemia (ATL).

83 etrovirus and the etiological agent of Adult T-cell Leukemia (ATLL).

84 f amphibian lymphocytes and the Jurkat human T cell leukemia cell line.

85 distinct signaling proteins in a panel of 13 T-cell leukemia cell lines treated with a gamma-secretas

86 Consistently, human adult T cell leukemia cells that acquire elevated APC(Cdc20) a

87 histone deacetylase 2 in erythroleukemia and T cell leukemia cells.

88 GBP with selective cytotoxicity toward human T-cell leukemia cells and indicate its potential use in

89 zomib (an agent whose cytotoxicity in Jurkat T-cell leukemia cells is dependent on Noxa) was examined

90 ked to a spectrum of diverse diseases: adult T cell leukemia, encephalomyelopathy, and predisposition

91 tudies, performed in translational models of T cell leukemia, establish a mechanism-based rationale f

92 HTLV) type 1, the etiological agent of adult T-cell leukemia, expresses the viral oncoprotein Tax1.

93 s in vitro and iNKT-cell-mediated control of T-cell leukemia growth in vivo.

94 This systems biology analysis defined T cell leukemia homeobox 1 (TLX1) and TLX3 as master reg

95 oncogene (encoding the transcription factor T cell leukemia homeobox protein-1) has a major role in

96 n proposed to have tumor suppressor roles in T-cell leukemia homeobox 1/3-transformed human T-ALL cel

97 NA binding site for the poorly characterized T-cell leukemia homeobox 3 (TLX3) TF was confirmed with

98 LIM homeobox transcription factor 1 beta and T-cell leukemia homeobox 3.

99 transduction pathway, commonly activated in T-cell leukemia in both mouse and man.

100 opoietic stem cell transplantation for adult T-cell leukemia in Japan.

101 ell leukemia virus 1 (HTLV-1)-mediated adult T cell leukemia is associated with the ability of viral

102 ood, Nagai et al provide evidence that adult T-cell leukemia is hierarchically organized and sustaine

103 leukemia virus type 1 (HTLV-1)-induced adult T-cell leukemia is linked to the expression of the viral

104 lective and potent cytotoxicity toward human T-cell leukemia Jurkat cells compared with a panel of ca

105 A CRISPR screen conducted in a CD4(+) T cell leukemia line has identified host factors require

106 he induction of apoptosis in Jurkat cells, a T-cell leukemia line.

107 , pTa, Gata3, and Runx1, in both Ikaros null T cell leukemia lines and Ikaros null primary thymocytes

108 -cell leukemia virus (HTLV)-associated adult T-cell leukemia lymphoma (ATLL) can be identified years

109 a lifelong infection and is linked to adult T-cell leukemia lymphoma (ATLL).

110 BZ) could be used for immunotherapy in adult T-cell leukemia-lymphoma (ATL) patients.

111 odification of host gene expression in adult T-cell leukemia-lymphoma (ATL).

112 d natural killer cell lymphoma and for adult T-cell leukemia-lymphoma.

113 on has only brought limited success in adult T cell leukemia/lymphoma (ATL) and in multiple sclerosis

114 kemia virus type 1 (HTLV-1)-associated adult T cell leukemia/lymphoma (ATL) cells as a model system.

115 Adult T cell leukemia/lymphoma (ATL) is an aggressive cancer o

116 ical spastic paraparesis (HAM/TSP), or adult T cell leukemia/lymphoma (ATL).

117 1 (HTLV-1) is the ethological agent of adult T cell leukemia/lymphoma (ATLL) and a number of lymphocy

118 Adult T cell leukemia/lymphoma (ATLL) is an aggressive maligna

119 In adult T cell leukemia/lymphoma (ATLL), the FoxP3(+) population

120 Deregulation of the T cell leukemia/lymphoma 1 (TCL1) oncogene in mouse B ce

121 ype 1 (HTLV-1) is a causative agent of adult T cell leukemia/lymphoma and a variety of inflammatory d

122 ical spastic paraparesis (HAM/TSP) and adult T cell leukemia/lymphoma.

123 e 1 (HTLV-1) is the causative agent of adult T cell leukemia/lymphoma.

124 virus type 1 (HTLV-1) infection causes adult T-cell leukemia/lymphoma (ATL) and is associated with a

125 d with the lymphoproliferative disease adult T-cell leukemia/lymphoma (ATL) and the neurodegenerative

126 In adult T-cell leukemia/lymphoma (ATL) cell lines and patient T

127 Adult T-cell leukemia/lymphoma (ATL) is an aggressive and fata

128 Adult T-cell leukemia/lymphoma (ATL) is an aggressive hematolo

129 Adult T-cell leukemia/lymphoma (ATL) is etiologically linked t

130 -cell leukemia virus type 1-associated adult T-cell leukemia/lymphoma (ATL) typically has survivals m

131 sactivator initiates transformation in adult T-cell leukemia/lymphoma (ATL), a highly aggressive chem

132 e 1 (HTLV-1) is the causative agent of adult T-cell leukemia/lymphoma (ATL), a malignancy of CD4(+) T

133 lts in a variety of diseases including adult T-cell leukemia/lymphoma (ATL).

134 to rapid progression in patients with adult T-cell leukemia/lymphoma (ATLL) (NCT02631746).

135 ), anaplastic large-cell lymphoma, and adult T-cell leukemia/lymphoma (ATLL) and a lower incidence of

136 r A (RHOA) hotspot mutations among the adult T-cell leukemia/lymphoma (ATLL) category have opposite b

137 Adult T-cell leukemia/lymphoma (ATLL) is an incurable disease

138 In IL-2-dependent cells and adult T-cell leukemia/lymphoma (ATLL) patient samples, however

139 ic virus type-1 (HTLV-1) that initiate adult T-cell leukemia/lymphoma (ATLL) remain unclear, in part

140 We recently reported the first case of adult T-cell leukemia/lymphoma (ATLL) that responded rapidly t

141 CD8(+) T cells, yet this virus causes adult T-cell leukemia/lymphoma (ATLL) that typically has a CD4

142 e 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia/lymphoma (ATLL).

143 astic type (18.5%), NKTCL (10.4%), and adult T-cell leukemia/lymphoma (ATLL; 9.6%).

144 T-cell leukemia/lymphoma 1 (TCL1) is an oncogene overexp

145 ouse studies indicate that activation of the T-cell leukemia/lymphoma 1 (TCL1) oncogene is a contribu

146 mmon human leukemia and dysregulation of the T-cell leukemia/lymphoma 1 (TCL1) oncogene is a contribu

147 The T-cell leukemia/lymphoma 1 (TCL1) oncogene is a target o

148 Here, we determined whether T-cell leukemia/lymphoma 1 (TCL1) oncoprotein encoded by

149 Deregulation of the T-cell leukemia/lymphoma 1 oncogene (TCL1) in mouse B ce

150 ive anaplastic large cell lymphoma, 14 adult T-cell leukemia/lymphoma and 44 extranodal NK/T-cell lym

151 e 1 (HTLV-1) is the causative agent of adult T-cell leukemia/lymphoma and HTLV-1-associated myelopath

152 causes two distinct pathologies termed adult T-cell leukemia/lymphoma and tropical spastic paraparesi

153 virus type 1 (HTLV-1) is the cause of adult T-cell leukemia/lymphoma as well as tropical spastic par

154 To study the impact of oncogenic K-Ras on T-cell leukemia/lymphoma development and progression, we

155 l recognized as a potential factor for adult T-cell leukemia/lymphoma development.

156 Adult T-cell leukemia/lymphoma has a homogeneous molecular sig

157 cogenic driver mutation, promotes aggressive T-cell leukemia/lymphoma in patient carriers, although t

158 Adult T-cell leukemia/lymphoma is a fatal malignancy etiologic

159 The human T-cell leukemia/lymphoma virus type 1 (HTLV-1) ORF-I enc

160 The human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p30 prote

161 logically linked to infection with the human T-cell leukemia/lymphoma virus type 1 (HTLV-I).

162 The persistence of human T-cell leukemia/lymphoma virus-I (HTLV-I)-infected cells

163 1 (HTLV-1) is the etiological agent of adult T-cell leukemia/lymphoma, and it encodes a number of non

164 l lymphoma, cutaneous T-cell lymphoma, adult T-cell leukemia/lymphoma, and other peripheral T-cell ly

165 ided highly diverse results on the issues of T-cell leukemia/lymphoma-initiating cells (T-LICs) and p

166 ts a major risk for the development of adult T-cell leukemia/lymphoma.

167 lastic large-cell lymphoma (ALCL), and adult T-cell leukemia/lymphoma.

168 e resulted in a highly penetrant, aggressive T-cell leukemia/lymphoma.

169 proliferation, which in turn leads to adult T-cell leukemia/lymphoma.

170 duced many elements of HTLV-associated adult T-cell leukemia/lymphoma.

171 ctivation in hematopoietic precursors caused T-cell leukemia/lymphomas (T-ALL) and pure red blood cel

172 t in a transgenic mouse model of MYC-induced T-cell leukemia, MYC, maintains self-renewal in Sca1(+)

173 d from patients with HTLV-I-associated adult T-cell leukemia or with progeria.

174 ferent human cancers including lymphoblastic T-cell leukemia, pancreatic cancer, melanoma and rhabdom

175 eripheral blood mononuclear cells from adult T-cell leukemia patients.

176 usative agents for cervical cancer and adult T-cell leukemia, respectively.

177 Adult patients with acute lymphoblastic T cell leukemia (T-ALL) have a very poor prognosis and f

178 te and cause myeloproliferative disorder and T cell leukemia (T-ALL) when induced in the bone marrow

179 nsmembrane protein highly expressed in acute T-cell leukemia (T-ALL) and in a subset of peripheral T-

180 ly in primary and secondary tissues, we used T-cell leukemia (TCL)1 cells reactive with the autoantig

181 An age of 10 years or older, T-cell leukemia, the presence of an 11q23 rearrangement,

182 The orf-I gene of human T-cell leukemia type 1 (HTLV-1) encodes p8 and p12 and h

183 The effects that human T cell leukemia virus (HTLV) type 1 and simian immunodef

184 The etiology of human T cell leukemia virus 1 (HTLV-1)-mediated adult T cell l

185 Ectopic expression of human T cell leukemia virus 1-encoded Tax protein, which resem

186 Infection by human T cell leukemia virus type 1 (HTLV-1) causes a fatal hem

187 Human T cell leukemia virus type 1 (HTLV-1) inhibits host anti

188 Human T cell leukemia virus type 1 (HTLV-1) is associated with

189 The human T cell leukemia virus type 1 (HTLV-1) is the causative a

190 Human T cell leukemia virus type 1 (HTLV-1) is the ethological

191 Human T cell leukemia virus type 1 (HTLV-1), also known as hum

192 ced apoptosis, we used TRAIL-resistant human T cell leukemia virus type 1 (HTLV-1)-associated adult T

193 cytes) to the total viral burden in 22 human T cell leukemia virus type 1 (HTLV-1)-infected individua

194 Human T cell leukemia virus type 1 and type 2 (HTLV-1 and -2)

195 Retroviral Tax proteins from human T cell leukemia virus type 1 and type 2 (HTLV-1 and -2)

196 ssociations in three viral infections: Human T cell Leukemia Virus type 1, Human Immunodeficiency Vir

197 Furthermore, the Tax oncoprotein of human T cell leukemia virus type I targeted this complex for i

198 l virus, human immunodeficiency virus, human T cell leukemia virus, human papilloma virus, hepatitis

199 Human T cell leukemia virus, type 1 (HTLV-1) replication and s

200 recognizes the foreign Ag Tax from the human T cell leukemia virus-1 when presented by the class I MH

201 sible link with the autoimmune disease human T cell leukemia virus-1-associated myelopathy/tropical s

202 Human T-cell leukemia virus (HTLV) regulatory protein, Rex, fu

203 The human T-cell leukemia virus (HTLV) type 1 transcriptional tran

204 Human T-cell leukemia virus (HTLV) type 1, the etiological age

205 ly discovered the antisense protein of human T-cell leukemia virus (HTLV) type 2 (APH-2), whose messe

206 demonstrate that driver mutations for human T-cell leukemia virus (HTLV)-associated adult T-cell leu

207 ntification of the genes necessary for human T-cell leukemia virus (HTLV-1) persistence in humans may

208 logically linked to infection with the human T-cell leukemia virus (HTLV-1).

209 cation and partial characterization of human T-cell leukemia virus (HTLV; now known as HTLV-1) produc

210 A role for microRNAs (miRNA) in human T-cell leukemia virus 1 (HTLV-1)-mediated cellular trans

211 12-O-Tetradecanoylphorbol-13-acetate, human T-cell leukemia virus 1 Tax, and CD40 did not.

212 Infection with human T-cell leukemia virus induces cellular genomic instabili

213 t of important human pathogens such as human T-cell leukemia virus type 1 (HTLV-1) and HIV-1.

214 Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 are clo

215 ence techniques in real time with both human T-cell leukemia virus type 1 (HTLV-1) and human immunode

216 Human T-cell leukemia virus type 1 (HTLV-1) and type 2 (HTLV-2

217 Human T-cell leukemia virus type 1 (HTLV-1) and type 2 (HTLV-2

218 Human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipp

219 et al report that vaccination against human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipp

220 Infection with human T-cell leukemia virus type 1 (HTLV-1) can cause a rare f

221 butes to HTLV-1 infectivity.IMPORTANCE Human T-cell leukemia virus type 1 (HTLV-1) causes a variety o

222 Human T-cell leukemia virus type 1 (HTLV-1) causes multiple pa

223 ally integrated form of the retrovirus human T-cell leukemia virus type 1 (HTLV-1) contains identical

224 rs proposed a model for this region of human T-cell leukemia virus type 1 (HTLV-1) Env in which expul

225 Human T-cell leukemia virus type 1 (HTLV-1) establishes a life

226 Human T-cell leukemia virus type 1 (HTLV-1) expression depends

227 Human T-cell leukemia virus type 1 (HTLV-1) has two late domai

228 Human T-cell leukemia virus type 1 (HTLV-1) infection and tran

229 Human T-cell leukemia virus type 1 (HTLV-1) infection causes a

230 Human T-cell leukemia virus type 1 (HTLV-1) is a complex retro

231 Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus as

232 Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus th

233 Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus, a

234 Surprisingly, the NC protein from human T-cell leukemia virus type 1 (HTLV-1) is an extremely po

235 Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic re

236 Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic re

237 Transcriptional activation of human T-cell leukemia virus type 1 (HTLV-1) is mediated by the

238 The particle structure of human T-cell leukemia virus type 1 (HTLV-1) is poorly characte

239 Human T-cell leukemia virus type 1 (HTLV-1) is the causative a

240 Human T-cell leukemia virus type 1 (HTLV-1) is the causative a

241 The complex retrovirus human T-cell leukemia virus type 1 (HTLV-1) is the causative a

242 The human T-cell leukemia virus type 1 (HTLV-1) is the cause of ad

243 Human T-cell leukemia virus type 1 (HTLV-1) is the etiologic a

244 Human T-cell leukemia virus type 1 (HTLV-1) is the etiological

245 Human T-cell leukemia virus type 1 (HTLV-1) is the etiological

246 Infection by the human T-cell leukemia virus type 1 (HTLV-1) is thought to caus

247 d, Fujikawa et al demonstrate that the human T-cell leukemia virus type 1 (HTLV-1) oncoprotein Tax in

248 In the present study, we show that the Human T-cell Leukemia Virus Type 1 (HTLV-1) oncoprotein Tax is

249 uggested to be largely dispensable for human T-cell leukemia virus type 1 (HTLV-1) particle biogenesi

250 Human T-cell leukemia virus type 1 (HTLV-1) propagates within

251 The role of autophagy in human T-cell leukemia virus type 1 (HTLV-1) replication has, h

252 Human T-cell leukemia virus type 1 (HTLV-1) Tax affects cellul

253 The human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein ac

254 -risk human papillomavirus (HPV) E6 or human T-cell leukemia virus type 1 (HTLV-1) Tax oncoproteins.

255 lishment of humanized mice infected by human T-cell leukemia virus type 1 (HTLV-1) that recapitulate

256 The glycoproteins from human T-cell leukemia virus type 1 (HTLV-1) were resistant to

257 In comparison, NC of human T-cell leukemia virus type 1 (HTLV-1), a deltaretrovirus

258 The retroviral oncoprotein Tax from human T-cell leukemia virus type 1 (HTLV-1), an etiological fa

259 udy, we found that HBZ, encoded by the Human T-cell Leukemia Virus type 1 (HTLV-1), binds to multiple

260 , which can result from infection with human T-cell leukemia virus type 1 (HTLV-1), is associated wit

261 infection by HIV-1, HIV-1Deltavif, and human T-cell leukemia virus type 1 (HTLV-1), while significant

262 Human T-cell leukemia virus type 1 (HTLV-1)-associated adult T

263 The etiology of human T-cell leukemia virus type 1 (HTLV-1)-induced adult T-ce

264 Disease development in human T-cell leukemia virus type 1 (HTLV-1)-infected individua

265 aggressive T-cell malignancy caused by human T-cell leukemia virus type 1 (HTLV-1).

266 infection with the complex retrovirus human T-cell leukemia virus type 1 (HTLV-1).

267 Human T-cell leukemia virus type 1 (HTLV-I) is associated with

268 Human T-cell leukemia virus type 1 (HTLV-I) is the etiological

269 s level of BIC by up to 70% in EBV- or human T-cell leukemia virus type 1 (HTLV1)-transformed cell li

270 The human T-cell leukemia virus type 1 oncoprotein Tax has pleiotr

271 The Tax oncoprotein encoded by the human T-cell leukemia virus type 1 plays a pivotal role in vir

272 Unlike the resistance of HIV-1 and human T-cell leukemia virus type 1 to hA3G, the resistance of

273 ion of additional human tumor viruses--human T-cell leukemia virus type 1, hepatitis C virus, and Kap

274 Human T-cell leukemia virus type 1-associated adult T-cell leu

275 Human T-cell leukemia virus type 1-infected cells proliferate

276 uman immunodeficiency virus type 1 and human T-cell leukemia virus type 1.

277 viruses in the transplant population: human T-cell leukemia virus type 1; hepatitis E virus; bocavir

278 Human T-cell leukemia virus type 2 (HTLV-2) Rex is a transacti

279 Human T-cell leukemia virus type I (HTLV-1) replication relies

280 Human T-cell leukemia virus type I (HTLV-I) encodes a Tax onco

281 The Human T-cell leukemia virus type I (HTLV-I) is the only known

282 The mechanisms by which the human T-cell leukemia virus type I (HTLV-I) Tax oncoprotein de

283 Human T-cell leukemia virus type I (HTLV-I)-associated maligna

284 Reports have shown that Tax, a human T-cell leukemia virus type I encoded protein that has be

285 ive hematological malignancy caused by human T-cell leukemia virus type-1 (HTLV-1).

286 g an oncogenic delta(delta)-retrovirus human T-cell leukemia virus type-1 (HTLV-1).

287 Human T-cell leukemia virus type-1 is the causative agent for

288 o nucleosomal templates containing the human T-cell leukemia virus type-1 promoter sequences.

289 Human T-cell leukemia virus type-I (HTLV-I) is the etiologic a

290 Human T-cell leukemia virus type-I expresses Tax, a 40-kDa onc

291 Human T-cell leukemia virus types 3 and 4 (HTLV-3 and HTLV-4)

292 teract with the C terminus of Tax-1 of human T-cell leukemia virus with micromolar affinity.

293 Infection with the human T-cell leukemia virus-1 (HTLV-1) results in a variety of

294 em cells (HSCs) and B cells, and that causes T-cell leukemia when overexpressed.

295 sease onset in murine models of Notch-driven T-cell leukemia, whether Dicer1-processed miRNAs are ess

296 ted mAb by immunizing mice with Jurkat acute T cell leukemia, which binds ILT3.Fc to its membrane.

297 vating IKK, yet only HTLV-1 infection causes T cell leukemia, which correlates with persistent activa

298 Adult T-cell leukemia, which can result from infection with hu

299 HTLV-1 mainly causes adult T cell leukemia, while HTLV-2 is not associated with leu

300 These data indicate that patients with T-cell leukemia with K-Ras mutations may benefit from th